AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

LabShares Newton Selects Savran Technologies as Winner of First Launch@LabShares Competition Valued at $50K

May 9, 2019

NEWTON, Mass.--(BUSINESS WIRE)--May 9, 2019--LabShares Newton, a shared office and laboratory incubator for emerging biotechnology and life science companies, announced today that Savran Technologies is the winner of the first Launch@LabShares competition, providing a $50K year-long membership, including scientific and operational support, to this novel diagnostics startup. This first Launch@LabShares award is sponsored by Faber Daeufer & Itrato, a life science focused corporate law firm, and DTWard PC, a biotech intellectual property law firm.

“We are thrilled to be able to welcome Savran Technologies as a member of the LabShares community,” said Jeff Behrens, co-founder and CEO of LabShares Newton. “As our tenth member and first winner of our Launch@LabShares award, Savran was selected based on their exciting microfluidic technology, which focuses on whole cell isolation for both prenatal and oncology diagnostics.”

Savran Technologies is a Massachusetts-based biotech company with a mission to revolutionize non-invasive diagnostics via isolation of ultra-rare cells. The company is developing applications for use in prenatal and oncology testing. In the prenatal market, isolating intact fetal cells from maternal blood is key to detecting many genetic anomalies missed by today’s blood tests using fetal DNA fragments. In oncology, liquid biopsies can be performed more frequently and less invasively.

“We are honored to be selected as the first Launch@LabShares winner and want to thank LabShares for this meaningful award as we grow the company,” said Kathryn Roy, CEO of Savran Technologies. “LabShares’ support is extremely valuable to us as we develop non-invasive diagnostics to transform oncology and prenatal testing.”

LabShares also announced today the second Launch@LabShares competition, offered in collaboration with the Massachusetts Technology Transfer Center’s (MTTC) 12th Annual Massachusetts Life Sciences Innovation (MALSI) Day and MassBio’s MassCONNECT Program. A second life science startup will be selected for a one-year membership also valued at $50K; the winner will be announced at the MALSI conference, being held on June 27, 2019, at 8:00 a.m.-7:00 p.m., at the Kendall Square Marriott in Cambridge. The MALSI conference is the flagship event of life science in Massachusetts, jointly and actively arranged by all the major organizations that are involved in supporting the life science start-up ecosystem in the Commonwealth.

Innovative, early-stage life science startups are encouraged to apply by June 7, 2019, at www.labshares.com/launch. The competition is open to biotechnology startups that are less than three years old, have raised less than $2M, have fewer than five employees, are headquartered in Massachusetts, and have a minimum of $250K in money raised or grants won.

For more information on LabShares, or to arrange a tour, please contact Hannah Schram at hannah@labshares.com.

About LabShares Newton, LLC

LabShares Newton is an office and laboratory incubator for emerging biotechnology and life science start-ups. The shared space provides a collaborative, affordable and entrepreneurial research environment for early-stage companies in a convenient location close to Cambridge and Boston. LabShares has developed a state-of-the-art facility that is fully permitted and professionally maintained and offers a variety of support services and amenities. For more information, please visit  www.labshares.com.

About MTTC/MALSI

Massachusetts Technology Transfer Center (MTTC)  helps inventors, researchers, and entrepreneurs bring innovative technologies from academic research institutions to the market. By providing access to capital, coaching, and connections, we accelerate the adoption of new technology, expedite startup activity, and expand economic impact statewide. MTTC expedites the transfer of new tech to local industries, fueling a crucial (sometimes missing) link in Massachusetts’ robust economic ecosystem.

About MassCONNECT

MassBio  is the biopharma industry association in Massachusetts. The Innovation Services team leverages MassBio’s extensive network to catalyze innovation. Working with scientists within academic institutions, startups, and big pharma, MassBio Innovation Services fosters collaborations by convening and connecting the different players in the innovation ecosystem.

MassBio’s  MassCONNECT  program is the only entrepreneur mentorship program in Massachusetts that dives deep into the life sciences. MassCONNECT matches entrepreneurs and founders with seasoned life sciences professionals to accelerate and commercialize innovation.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190509005716/en/

CONTACT: Corporate Contact:

LabShares Newton

Jenna Stein, 857-222-5817

jenna@labshares.comMedia Contact:

Rozen Communications

Michele Rozen, 617-953-2214

michele@rozencommunications.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY RESEARCH SCIENCE

SOURCE: LabShares Newton

Copyright Business Wire 2019.

PUB: 05/09/2019 11:48 AM/DISC: 05/09/2019 11:48 AM

http://www.businesswire.com/news/home/20190509005716/en